Immuron Announces Proposed Public Offering of ADSs
16 juil. 2019 16h31 HE
|
Immuron Limited
MELBOURNE, Australia, July 16, 2019 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral...
Immuron Prices Underwritten Public Offering of ADSs
23 mai 2019 21h10 HE
|
Immuron Limited
MELBOURNE, Australia,, May 23, 2019 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral...
Immuron Announces Proposed Public Offering of ADSs
23 mai 2019 16h45 HE
|
Immuron Limited
MELBOURNE, Australia, May 23, 2019 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral immunoglobulin...